These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10721681)

  • 21. A comparison of citalopram and paroxetine in the treatment of panic disorder: a randomized, single-blind study.
    Perna G; Bertani A; Caldirola D; Smeraldi E; Bellodi L
    Pharmacopsychiatry; 2001 May; 34(3):85-90. PubMed ID: 11434404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of paroxetine for relapse prevention in social anxiety disorder: a 24-week study.
    Stein DJ; Versiani M; Hair T; Kumar R
    Arch Gen Psychiatry; 2002 Dec; 59(12):1111-8. PubMed ID: 12470127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sertraline in the treatment of anxiety disorders.
    Hirschfeld RM
    Depress Anxiety; 2000; 11(4):139-57. PubMed ID: 10945134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Citalopram for treatment-resistant obsessive-compulsive disorder.
    Pallanti S; Quercioli L; Paiva RS; Koran LM
    Eur Psychiatry; 1999 Apr; 14(2):101-6. PubMed ID: 10572334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The structure of phobias in panic disorder.
    Argyle N; Solyom C; Solyom L
    Br J Psychiatry; 1991 Sep; 159():378-82. PubMed ID: 1958949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Neurobiology and pharmacotherapy of social phobia].
    Aouizerate B; Martin-Guehl C; Tignol J
    Encephale; 2004; 30(4):301-13. PubMed ID: 15538306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder.
    Ballenger JC; Wheadon DE; Steiner M; Bushnell W; Gergel IP
    Am J Psychiatry; 1998 Jan; 155(1):36-42. PubMed ID: 9433336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phobic symptoms as predictors of nonresponse to drug therapy in panic disorder patients (a preliminary report).
    Slaap BR; van Vliet IM; Westenberg HG; den Boer JA
    J Affect Disord; 1995 Jan; 33(1):31-8. PubMed ID: 7714306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Citalopram as an adjuvant in chronic schizophrenia: a double-blind placebo-controlled study.
    Salokangas RK; Saarijärvi S; Taiminen T; Kallioniemi H; Lehto H; Niemi H; Tuominen J; Ahola V; Syvälahti E
    Acta Psychiatr Scand; 1996 Sep; 94(3):175-80. PubMed ID: 8891083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A double-blind, placebo-controlled study of a flexible dose of venlafaxine ER in adult outpatients with generalized social anxiety disorder.
    Rickels K; Mangano R; Khan A
    J Clin Psychopharmacol; 2004 Oct; 24(5):488-96. PubMed ID: 15349004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression.
    Feighner JP; Overø K
    J Clin Psychiatry; 1999 Dec; 60(12):824-30. PubMed ID: 10665628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Citalopram intravenous infusion in resistant obsessive-compulsive disorder: an open trial.
    Pallanti S; Quercioli L; Koran LM
    J Clin Psychiatry; 2002 Sep; 63(9):796-801. PubMed ID: 12363120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder.
    Pollack M; Mangano R; Entsuah R; Tzanis E; Simon NM; Zhang Y
    Psychopharmacology (Berl); 2007 Oct; 194(2):233-42. PubMed ID: 17589833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Citalopram: new indication. No advantage.
    Prescrire Int; 1999 Feb; 8(39):18-9. PubMed ID: 10557570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Social phobia: the clinical efficacy and tolerability of the monoamine oxidase -A and serotonin uptake inhibitor brofaromine. A double-blind placebo-controlled study.
    Fahlén T; Nilsson HL; Borg K; Humble M; Pauli U
    Acta Psychiatr Scand; 1995 Nov; 92(5):351-8. PubMed ID: 8619339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Double-blind, placebo-controlled assessment of combined clonazepam with paroxetine compared with paroxetine monotherapy for generalized social anxiety disorder.
    Seedat S; Stein MB
    J Clin Psychiatry; 2004 Feb; 65(2):244-8. PubMed ID: 15003080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paroxetine, clomipramine, and cognitive therapy in the treatment of panic disorder.
    Bakker A; van Dyck R; Spinhoven P; van Balkom AJ
    J Clin Psychiatry; 1999 Dec; 60(12):831-8. PubMed ID: 10665629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy and safety of moclobemide compared to clomipramine in the treatment of panic disorder.
    Krüger MB; Dahl AA
    Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 1():S19-24. PubMed ID: 10361962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Escitalopram in specific phobia: results of a placebo-controlled pilot trial.
    Alamy S; Wei Zhang ; Varia I; Davidson JR; Connor KM
    J Psychopharmacol; 2008 Mar; 22(2):157-61. PubMed ID: 18208904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The peculiarities of panic disorders determined by gender dimorphism].
    Vorob'eva OV; Vasil'chikova NV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(6):9-13. PubMed ID: 15285628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.